Search

Each record is a registered study, a systematic-review registration or a publication. A registered or ongoing study is not a finding, and animal or cell research does not show an effect in people. The same study can appear under more than one subject, so the number of records is not a count of independent studies. You can also search an exact DOI, PubMed ID, NCT or CRD number. How to read these records.

16 study records (showing up to 30 per record type)

• Registered trial NCT05943158 Completed (results not assessed here)
  Myoinositol Effect on Asprosin Levels
  Condition or outcome area: Pregnancy Related
  2021-06-01 · Subject: Myoinositol; Inositol; inositol b; D-myo-inositol; D-Chiro-Inositol; cocositol; Chiro-inositol; inositol c; KS-00001292; TR-022051 · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT05951309 Completed (results not assessed here)
  Myoinositol Treatment and Asprosin Levels in PCOS
  Condition or outcome area: PCOS|Insulin Resistance
  2021-09-01 · Subject: Inositol; (2R,3S,5R,6R)-(113C)cyclohexane-1,2,3,4,5,6-hexol; mesoinositol; Myo-inositol; i-inositol; Inositol-c; scyllo-insitol · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT05943158 Completed (results not assessed here)
  Myoinositol Effect on Asprosin Levels
  Condition or outcome area: Pregnancy Related
  2021-06-01 · Subject: Inositol; (2R,3S,5R,6R)-(113C)cyclohexane-1,2,3,4,5,6-hexol; mesoinositol; Myo-inositol; i-inositol; Inositol-c; scyllo-insitol · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT03673995 Completed (results not assessed here)
  Myoinositol Plus L-tyrosine, Selenium and Chromium in PCOS
  Condition or outcome area: Polycystic Ovary Syndrome|Menstrual Problem|Hirsutism
  2017-05-02 · Subject: (S)-Tyrosine; Tyrosine; L-Tyr; HSDB 2003; L-[U-14C]Tyr; L-Phenylalanine-4-hydroxy-; s4608; CS-8013; N-acetyl-o-(dihydroxymethylsilyl)-; HY-N0473 · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT05228184 Phase 4 Not completed: Active Not Recruiting
  Use of Tirosint®-SOL or Tablet Formulations of Levothyroxine in Pediatric Patients With Congenital Hypothyroidism (CH)
  Condition or outcome area: Congenital Hypothyroidism
  2022-01-21 · Subject: 3,5,3',5'-Tetraiodothyronine; Levothyroxine · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT00000322 Phase 2 Completed (results not assessed here)
  Tyrosine for Methamphetamine Dependence - 1
  Condition or outcome area: Amphetamine-Related Disorders
  1997-04 · Subject: (S)-Tyrosine; Tyrosine; L-Tyr; HSDB 2003; L-[U-14C]Tyr; L-Phenylalanine-4-hydroxy-; s4608; CS-8013; N-acetyl-o-(dihydroxymethylsilyl)-; HY-N0473 · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT01088607 Phase 1 Completed (results not assessed here)
  Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
  Condition or outcome area: Primary Sclerosing Cholangitis
  2010-10 · Subject: Ursodeoxycholic Acid; Ursodeoxycholic acid; ursodeoxycholicacid · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT04549194 Completed (results not assessed here)
  Contribution of L-Tyrosine to Recovery From Operational Strain on Return From External Operation
  Condition or outcome area: Stress, Psychological
  2020-09-09 · Subject: (S)-Tyrosine; Tyrosine; L-Tyr; HSDB 2003; L-[U-14C]Tyr; L-Phenylalanine-4-hydroxy-; s4608; CS-8013; N-acetyl-o-(dihydroxymethylsilyl)-; HY-N0473 · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT04518254 Completed (results not assessed here)
  Contribution of L-Tyrosine to Human Decision Making in Stressful Situations
  Condition or outcome area: Stress, Psychological
  2021-11-18 · Subject: (S)-Tyrosine; Tyrosine; L-Tyr; HSDB 2003; L-[U-14C]Tyr; L-Phenylalanine-4-hydroxy-; s4608; CS-8013; N-acetyl-o-(dihydroxymethylsilyl)-; HY-N0473 · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT02259049 Early_Phase 1 Completed (results not assessed here)
  The Effects of L-Tyrosine on 24 Hour Blood Pressure and Heart Rate in Parkinson's Disease
  Condition or outcome area: Blood Pressure
  2014-10 · Subject: (S)-Tyrosine; Tyrosine; L-Tyr; HSDB 2003; L-[U-14C]Tyr; L-Phenylalanine-4-hydroxy-; s4608; CS-8013; N-acetyl-o-(dihydroxymethylsilyl)-; HY-N0473 · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT01913925 Completed (results not assessed here)
  Effect of Tyrosine Supplementation on Cognitive Performance and Mood During Military Stress
  Condition or outcome area: Reaction to Severe Stress, Unspecified
  2009-07 · Subject: (S)-Tyrosine; Tyrosine; L-Tyr; HSDB 2003; L-[U-14C]Tyr; L-Phenylalanine-4-hydroxy-; s4608; CS-8013; N-acetyl-o-(dihydroxymethylsilyl)-; HY-N0473 · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT01676103 Phase 1 / Phase 2 Completed (results not assessed here)
  The Effects of Supplementing Tyrosine on Blood Pressure in Parkinson's Disease
  Condition or outcome area: Parkinson's Disease
  2012-09 · Subject: (S)-Tyrosine; Tyrosine; L-Tyr; HSDB 2003; L-[U-14C]Tyr; L-Phenylalanine-4-hydroxy-; s4608; CS-8013; N-acetyl-o-(dihydroxymethylsilyl)-; HY-N0473 · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT01494766 Completed (results not assessed here)
  Efficacy of Tyrosine in Restless Legs Syndrome
  Condition or outcome area: Restless Legs Syndrome (RLS)
  2012-01 · Subject: (S)-Tyrosine; Tyrosine; L-Tyr; HSDB 2003; L-[U-14C]Tyr; L-Phenylalanine-4-hydroxy-; s4608; CS-8013; N-acetyl-o-(dihydroxymethylsilyl)-; HY-N0473 · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT03799094 Phase 1 / Phase 2 Not completed: Unknown
  Vitamin C and Tyrosine Kinase Inhibitor in Lung Cancer Patients With Epidermal Growth Factor Receptor Mutations
  Condition or outcome area: Carcinoma, Non-Small-Cell Lung
  2018-12-05 · Subject: L-Ascorbic Acid; Ascorbic acid; l-ascorbic acid · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT00001696 Phase 1 Completed (results not assessed here)
  A Pharmacokinetic Study of Genistein, a Tyrosine Kinase Inhibitor
  Condition or outcome area: Cancer
  1998-04 · Subject: Genistein; BSPBio_002375; Lopac-G-6649; NCGC00015479-02; K00046; Genisteol; Spectrum_000320; NCGC00025005-01; Sophoricol; KBio2_003368 · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT02978339 Phase 1 / Phase 2 Completed (results not assessed here)
  A Study Evaluating the Safety and Efficacy of Curcumin in Patients With Primary Sclerosing Cholangitis (PSC)
  Condition or outcome area: Primary Sclerosing Cholangitis
  2017-06-09 · Subject: Curcumin; (1E,4Z,6E)-5-hydroxy-1,7-bis(4-hydroxy-3-methoxy-phenyl)hepta-1,4,6-trien-3-one; C10443; BSPBio_003590; NCGC00095321-01; KBio3_003004; InChI=1/C21H20O6/c1-26-20-11-14(5-9-18(20)24)3-7-16(22)13-17(23)8-4-15-6-10-19(25)21(12-15)27-2/h3-13,22,24-25H,1-2H3/b7-3+,8-4+,16-13; curcumin ; diferuloylmethane; 5-hydroxy-1,7-bis(4-hydroxy-3-methoxy-phenyl)hepta-1,4,6-trien-3-one · open the ingredient record · ClinicalTrials.gov